Exchange: NSE Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
0.93% INR103.00
America/New_York / 8 mai 2024 @ 05:44
FUNDAMENTALS | |
---|---|
MarketCap: | 2 703.41 mill |
EPS: | -9.51 |
P/E: | -10.83 |
Earnings Date: | May 27, 2024 |
SharesOutstanding: | 26.25 mill |
Avg Daily Volume: | 0.0410 mill |
RATING 2024-05-07 |
---|
C+ |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Strong Sell | |
Return On Asset: | Neutral | |
DE: | Sell | |
P/E: | Strong Sell | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | n/a | n/a | n/a | |||
Debt | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -10.83 | sector: PE 0 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -10.83 | industry: PE 0 |
DISCOUNTED CASH FLOW VALUE |
---|
INR-83.74 (-181.30%) INR-186.74 |
Date: 2024-05-08 |
Expected Trading Range (DAY) |
---|
INR 97.91 - 108.09 ( +/- 4.94%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 |
Volume Signals | |
---|---|
Price | INR103.00 (0.93% ) |
Volume | 0.0249 mill |
Avg. Vol. | 0.0410 mill |
% of Avg. Vol | 60.72 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Brooks Laboratories Limited manufactures and sells pharmaceuticals on contract basis in India and internationally. It offers carbapenem drugs; tablets; dry syrup; liquid and dry power injections; and eye and ear drop. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.